InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.59
(
0.18%
)
US TECH 100
19,422.00
(
0.52%
)
Dow Jones
42,116.67
(
-0.02%
)
Brent Oil
74.34
(
0.81%
)
Bitcoin
63,944.77
(
0.97%
)
Post# of 451
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

BottomBounce

Send PM Follow Ignore
Followers 897
Posts 149194
Boards Moderated 0
Alias Born 08/13/2010

BottomBounce

Re: joe botts post# 407

Wednesday, 08/18/2021 8:42:12 PM

Wednesday, August 18, 2021 8:42:12 PM

Post# of 451
FDA Approval on $CEMI - $CEMI Chembio Diagnostics Got a FDA Emergency Use Nod For Its COVID-19 Antibody Test

The FDA has granted emergency use authorization to Chembio Diagnostics Inc's (NASDAQ: CEMI) COVID-19 antibody test.
The nod comes for LumiraDx SARS-CoV-2 Ab Test, a microfluidic immunofluorescence assay for the qualitative detection of total antibodies in whole human blood, plasma, or serum for indication of recent or prior infection.
Recently, the Company received a $28 million order to supply DPP SARS-CoV-2 Antigen tests for delivery during 2021 in Brazil.

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up